Thermo Fisher Scientific Inc., US8835561023

TD Cowen raises target for Thermo Fisher Scientific stock to USD 760

Published on 10/16/2026 at 09:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue hit USD 11.99 billion on July 23, 2026, up 10.50 percent year over year. Thermo Fisher Scientific stock costs EUR 621.60 on October 16, 2026.

Analyst target and quarterly evidence

TD Cowen set a USD 760.00 target on October 13, 2026.
Quarterly revenue reached USD 11.99 billion on July 23, 2026, up 10.50 percent year over year.
Thermo Fisher Scientific stock traded at EUR 621.60 at 9:01 a.m. CEST at Lang & Schwarz on October 16, 2026.

Bunte Pop-Art-Illustration eines Wissenschaftlers mit Reagenzglas im Comic-Stil — Pop-Art-Comic feiert Thermo Fisher Sci. US8835561023 mit farbenfrohem Wissenschaftler, Reagenzglas und knalligen Comic-Explosionslinien, Illustration mit AI erstellt.

Thermo Fisher Scientific (ISIN US8835561023) was trading at EUR 621.60 at Lang & Schwarz on October 16, 2026, at 9:01 a.m. CEST. Markets Insider reported that TD Cowen raised its price target to USD 760.00 from USD 675.00 on October 13, 2026, while keeping a Buy rating.

Target revision adds a clear benchmark

The new TD Cowen target is 12.59 percent above the former target, giving the latest analyst action a measurable change rather than a simple rating repetition. The firm cited a third-quarter earnings preview and improving demand trends in pharma and biotech, according to Markets Insider.

Thermo Fisher's recent quarterly figures provide the operating reference. MarketBeat reported revenue of USD 11.99 billion for the quarter announced on July 23, 2026, up 10.50 percent year over year. Adjusted earnings per share came to USD 6.03, versus consensus of USD 5.71, a 5.60 percent beat.

What does the target change mean?

The target revision places valuation expectations above the latest reported market reference in the source material, but the target is denominated in USD and is not a euro price comparison. MarketBeat also reported fiscal 2026 adjusted earnings-per-share guidance of USD 24.93 to USD 25.33 and a consensus target of USD 635.55 on October 8, 2026. Those figures frame the USD 760.00 target as an optimistic analyst view rather than company guidance.

Three target moves set the chronology

Transcript Daily listed three recent target actions: Barclays raised its target to USD 750.00 from USD 650.00 on October 7, 2026; Morgan Stanley raised its target to USD 730.00 from USD 650.00 on October 12, 2026; and TD Cowen raised its target to USD 760.00 from USD 675.00 on October 13, 2026.

Euro quote after the target revision

Thermo Fisher Scientific has a market capitalization of USD 257.5 billion as of October 15, 2026. The stock's primary listing is on the NYSE, where MarketBeat reported a USD 435.27 to USD 694.33 52-week range on October 8, 2026.

The euro quotation gives German investors a live reference during the Xetra session, while the analyst targets and operating figures remain in USD. The next major company catalyst is the forthcoming quarterly reporting cycle, which analysts used as the basis for the October target revisions.

Thermo Fisher Scientific was trading at EUR 621.60 at Lang & Schwarz on October 16, 2026, at 9:01 a.m. CEST.

The further course of trading is shown by the continuously updated real-time quote of Thermo Fisher Scientific stock.